blinatumomab
amgen,astellas
['blinatumomab']
congress|ash22|poster , discusses predictors of vod of the liver for pts treated with ino containing regimen in b-cell all. fractionation of ino doses, avoiding concurrent azole antifungals &amp; use of udca prophylaxis &amp; peri-sct period might alleviate risks 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm